News
I celebrated five years since my bone marrow transplant with a surprise video from my donor, a beautiful reminder of the life ...
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 ...
Insider Monkey on MSN18h
Syndax’s Revuforj Granted FDA Priority Review for Relapsed/Refractory Mutant NPM1 AMLSyndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the most promising stocks according to Wall Street analysts. On June 24, ...
10h
TipRanks on MSNMoleculin Biotech Gains Approval for Phase 2B/3 AML StudyAn announcement from Moleculin Biotech ( ($MBRX) ) is now available. On July 9, 2025, Moleculin Biotech announced that the Regulation Agency for ...
Longtime followers of Bravo's The Valley recently noticed that Jared Lipscomb, who some may recall from early episodes of ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial Recent EU approval from the European Medicines Agency (EMA) boosts ...
TURKU, FI / ACCESS Newswire / July 9, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - The oral presentation and poster showcase bexmarilimab's dual attack on cancer with new mechanistic data from ...
Moleculin Biotech (MBRX) announced that the Regulation Agency for Medical and Pharmaceutical Activities, or RAMPA, in the country of Georgia has ...
7h
Nottinghamshire Live on MSNPast use of Tollerton Airfield ‘being taken seriously’ as campaigners say they’re ‘concerned as hell’The subsequent report, first published in 2008 and seen by the Local Democracy Reporting Service, concluded: “The possibility of residual radium contamination at the Tollerton site exists, however the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results